Raymond Levy

8.4k total citations · 3 hit papers
82 papers, 6.7k citations indexed

About

Raymond Levy is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Raymond Levy has authored 82 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Psychiatry and Mental health, 21 papers in Cognitive Neuroscience and 11 papers in Physiology. Recurrent topics in Raymond Levy's work include Dementia and Cognitive Impairment Research (28 papers), Functional Brain Connectivity Studies (15 papers) and Schizophrenia research and treatment (14 papers). Raymond Levy is often cited by papers focused on Dementia and Cognitive Impairment Research (28 papers), Functional Brain Connectivity Studies (15 papers) and Schizophrenia research and treatment (14 papers). Raymond Levy collaborates with scholars based in United Kingdom, United States and Poland. Raymond Levy's co-authors include Robin Jacoby, Barbara J. Sahakian, Michael Philpot, Alistair Burns, Robert Howard, Gemma Jones, David M. Warburton, Jeffrey A. Gray, Melanie Abas and Trevor W. Robbins and has published in prestigious journals such as The Lancet, Brain and Biological Psychiatry.

In The Last Decade

Raymond Levy

80 papers receiving 6.2k citations

Hit Papers

The detection of psychiatric illness by questionnaire 1973 2026 1990 2008 1973 1988 1994 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond Levy United Kingdom 32 2.8k 1.5k 1.1k 1.0k 891 82 6.7k
Reinhard Heun Germany 51 2.6k 1.0× 1.4k 1.0× 1.2k 1.0× 489 0.5× 1.8k 2.0× 214 8.0k
Wolfgang Maier Germany 49 2.3k 0.8× 1.3k 0.9× 1.1k 1.0× 706 0.7× 546 0.6× 172 7.1k
David Chant Australia 33 4.1k 1.5× 787 0.5× 1.9k 1.7× 902 0.9× 557 0.6× 108 8.6k
José Luis Vázquez‐Barquero Spain 49 4.0k 1.4× 1.0k 0.7× 2.2k 1.9× 875 0.9× 552 0.6× 148 7.4k
Barry J. Gurland United States 42 2.7k 1.0× 497 0.3× 772 0.7× 1.2k 1.2× 1.1k 1.2× 131 7.4k
Carl Eisdorfer United States 44 1.7k 0.6× 732 0.5× 1.1k 1.0× 1.1k 1.1× 760 0.9× 179 6.8k
Matti Isohanni Finland 51 4.6k 1.7× 1.1k 0.7× 2.7k 2.4× 776 0.8× 676 0.8× 237 9.0k
Lawrence J. Whalley United Kingdom 54 2.9k 1.0× 1.5k 1.0× 939 0.8× 463 0.5× 1.6k 1.8× 215 10.8k
A. S. Henderson Australia 55 3.7k 1.3× 903 0.6× 2.1k 1.8× 1.3k 1.3× 1.3k 1.4× 137 9.2k
Yvonne Forsell Sweden 50 2.2k 0.8× 818 0.6× 1.7k 1.5× 1.2k 1.2× 1.1k 1.2× 183 7.2k

Countries citing papers authored by Raymond Levy

Since Specialization
Citations

This map shows the geographic impact of Raymond Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Levy more than expected).

Fields of papers citing papers by Raymond Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Levy. The network helps show where Raymond Levy may publish in the future.

Co-authorship network of co-authors of Raymond Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Levy. A scholar is included among the top collaborators of Raymond Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Levy. Raymond Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abas, Melanie, et al.. (1998). Culturally sensitive validation of screening questionnaires for depression in older African– Caribbean people living in south London. The British Journal of Psychiatry. 173(3). 249–254. 41 indexed citations
2.
Hill, Katie, et al.. (1995). User expectations of a memory clinic. Clinical Psychology Forum. 1(83). 9–11. 15 indexed citations
3.
Förstl, Hans, Alistair Burns, Raymond Levy, & Nigel J. Cairns. (1994). Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease. The British Journal of Psychiatry. 165(1). 53–59. 129 indexed citations
4.
Howard, Robert, et al.. (1994). Quantitative Magnetic Resonance Imaging Volumetry Distinguishes Delusional Disorder from Late-Onset Schizophrenia. The British Journal of Psychiatry. 165(4). 474–480. 43 indexed citations
5.
Sahakian, Barbara J., Adrian M. Owen, Nicola Morant, et al.. (1993). Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology. 110(4). 395–401. 200 indexed citations
6.
O’Brien, John T., et al.. (1992). How well do we manage families with genetic problems?. BMJ. 304(6818). 6.3–6. 1 indexed citations
7.
Eagger, Sarah, Raymond Levy, & Barbara J. Sahakian. (1992). Tacrine in Alzheimer's disease. Acta Neurologica Scandinavica. 85(S139). 75–80. 11 indexed citations
8.
Eagger, Sarah, Nicola Morant, Raymond Levy, & Barbara J. Sahakian. (1992). Tacrine in Alzheimer's Disease. The British Journal of Psychiatry. 160(1). 36–40. 75 indexed citations
9.
Trinkle, David, Alistair Burns, & Raymond Levy. (1992). Brief report: Abnormal eating behavior in dementia—a descriptive study. International Journal of Geriatric Psychiatry. 7(11). 799–803. 10 indexed citations
10.
O’Brien, John T., et al.. (1991). Effects of Tetrahydroaminoacridine on Liver Function in Patients with Alzheimer's Disease. Age and Ageing. 20(2). 129–131. 43 indexed citations
11.
Burns, Alistair, Robin Jacoby, & Raymond Levy. (1991). Computed tomography in Alzheimer's disease: A longitudinal study. Biological Psychiatry. 29(4). 383–390. 27 indexed citations
12.
Burns, Alistair, Robin Jacoby, Michael Philpot, & Raymond Levy. (1991). Computerised Tomography in Alzheimer's Disease. The British Journal of Psychiatry. 159(5). 609–614. 27 indexed citations
13.
Burns, Alistair, Glyn Lewis, Robin Jacoby, & Raymond Levy. (1991). Factors affecting survival in Alzheimer's disease. Psychological Medicine. 21(2). 363–370. 120 indexed citations
14.
Hajimohammadreza, Iradj, Michael J. Brammer, Sarah Eagger, Alistair Burns, & Raymond Levy. (1990). Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1025(2). 208–214. 61 indexed citations
15.
Abas, Melanie, Barbara J. Sahakian, & Raymond Levy. (1990). Neuropsychological deficits and CT scan changes in elderly depressives. Psychological Medicine. 20(3). 507–520. 211 indexed citations
16.
Eagger, Sarah, et al.. (1990). Platelet membrane fluidity, family history, severity and age of onset in Alzheimer's disease. International Journal of Geriatric Psychiatry. 5(6). 395–400. 8 indexed citations
17.
Sahakian, Barbara J., Gemma Jones, Raymond Levy, Jeffrey A. Gray, & David M. Warburton. (1989). The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type. The British Journal of Psychiatry. 154(6). 797–800. 415 indexed citations
18.
Levy, Raymond, et al.. (1987). Late paraphrenia: Neuropsychological impairment and structural brain abnormalities on computed tomography. International Journal of Geriatric Psychiatry. 2(2). 83–90. 92 indexed citations
19.
Levy, Raymond, et al.. (1987). Genetic Markers in Late Paraphrenia: A Study of HLA Antigens. The British Journal of Psychiatry. 150(1). 124–127. 20 indexed citations
20.
Hicks, Nicholas, et al.. (1987). PLATELET MEMBRANE PROPERTIES IN ALZHEIMER AND MULTI-INFARCT DEMENTIAS. Alzheimer Disease & Associated Disorders. 1(2). 90–97. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026